• Open Access COVID-19 Drug Discovery Project Launched

    Aionics introduces the Open Access COVID-19 Drug Discovery Project, a collaborative effort between Aionics and Stanford University to provide a public version of the Aionics machine learning (ML) modeling suite to accelerate the search for potential new SARS-CoV-2 therapeutic drugs.

    Read More